Related Experiment Video
Updated: Jul 25, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
Signal transduction by the CEACAM1 tumor suppressor. Phosphorylation of serine 503 is required for growth-inhibitory
1Department of Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Abstract:
CEACAM1 is a cell-cell adhesion molecule that mediates homophilic cell adhesion. In addition, CEACAM1 was also shown to suppress the growth of prostate, breast, and colon tumors. Structural and functional analyses showed that the adhesion activity of CEACAM1 is mediated by its extracellular domain while its cytoplasmic domain is necessary and sufficient for growth-inhibitory activity. The signal pathways leading to CEACAM1-mediated growth suppression are not known. We studied the importance of phosphorylation of serine 503 in this growth-inhibitory signaling pathway. Full-length CEACAM1 was found to be phosphorylated in vivo in both tyrosine and serine residues. Mutation of tyrosine 488 to phenylalanine did not abolish the tumor-suppressive activity of CEACAM1, suggesting that phosphorylation at tyrosine 488 is not critical for CEACAM1's tumor-suppressive activity. Although expression of CEACAM1's cytoplasmic domain inhibited the growth of DU145 prostate cancer cells in vivo, mutation of serine 503 to alanine abolished the growth-inhibitory activity. In addition, the change of serine 503 to aspartic acid produced tumor-suppressive activity similar to that of the wild-type CEACAM1. These results suggested that phosphorylation at serine 503 is essential for CEACAM1's growth-inhibitory function in vivo.
Insights
Phosphorylation of serine 503 in CEACAM1 is crucial for its tumor-suppressive activity. This finding is vital for understanding CEACAM1
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- CEACAM1 is a cell-cell adhesion molecule with demonstrated tumor-suppressive roles in prostate, breast, and colon cancers.
- CEACAM1's extracellular domain mediates adhesion, while its cytoplasmic domain is key for growth inhibition.
- The precise signaling pathways underlying CEACAM1's tumor suppression remain largely unknown.
Purpose of the Study:
- To investigate the role of serine 503 phosphorylation in the growth-inhibitory signaling pathway of CEACAM1.
- To determine the significance of tyrosine 488 and serine 503 phosphorylation for CEACAM1's tumor-suppressive function.
Main Methods:
- Analysis of in vivo phosphorylation of full-length CEACAM1 at tyrosine and serine residues.
- Site-directed mutagenesis of tyrosine 488 to phenylalanine and serine 503 to alanine or aspartic acid.
- Assessment of the impact of these mutations on CEACAM1's growth-inhibitory activity in DU145 prostate cancer cells.
Main Results:
- CEACAM1 is phosphorylated on both tyrosine and serine residues in vivo.
- Mutation of tyrosine 488 did not affect CEACAM1's tumor-suppressive activity.
- Mutation of serine 503 to alanine abolished growth inhibition, while mutation to aspartic acid mimicked wild-type activity.
Conclusions:
- Phosphorylation at serine 503 is essential for the in vivo tumor-suppressive function of CEACAM1.
- Tyrosine 488 phosphorylation is not critical for CEACAM1's growth-inhibitory role.
- These findings elucidate a key mechanism in CEACAM1-mediated cancer growth suppression.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade
PI3K/mTOR/AKT Signaling Pathway
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

